✦ LIBER ✦

Prevention of cardiovascular diseases: creating a healthy environment

✍ Scribed by Dominik Ose; Tobias Freund; Sabine Ludt

Publisher: Springer
Year: 2011
Tongue: English
Weight: 68 KB
Volume: 20
Category: Article
ISSN: 1741-3842
DOI: 10.1007/s10389-011-0463-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of cancer and cardiovascular

Prevention of cancer and cardiovascular diseases: A common strategy?

✍ Josep M. Argilés; Neus Carbó; Paola Costelli; Francisco J. López-Soriano 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Cancer and cardiovascular diseases are two pathological states involving uncontrolled proliferation of either tumor or vascular smooth muscle cells. Interestingly, both types of disease can be prevented by the same type of chemical agent, such as marine polyunsaturated fatty acids, sulfur-containing

Making cardiovascular disease prevention

Making cardiovascular disease prevention a reality

✍ Philip Greenland; Laura L. Hayman 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 467 KB

Primary prevention of cardiovascular dis

Primary prevention of cardiovascular disease—how to promote healthy eating habits in populations?

✍ C. von Schacky 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 153 KB

Humanistic behaviorism: A tool for creat

Humanistic behaviorism: A tool for creating healthy learning environments

✍ Vernon F. Jones 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Women and Cardiovascular Disease—Prevent

Women and Cardiovascular Disease—Prevention of Heart Disease

✍ Thomas F. Whayne 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 100 KB

Treating fatty liver for the prevention

Treating fatty liver for the prevention of cardiovascular diseases

✍ Federico Salamone; Fabio Galvano; Giovanni Li Volti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi